Merck & Co., Inc. is 7.4x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($294.13 B vs $39.81 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TEVA | MRK |
|---|---|---|
| Market cap | $39.81 B | $294.13 B |
| US-listed rank | #383 | #44 |
| Revenue (latest FY) | $17.26B | $65.01B |
| Net income (latest FY) | $1.41B | $18.25B |
| Net margin | 8.2% | 28.1% |
| P/E (trailing FY) | 28.2 | 16.1 |
| SEC filings | 2,473 | 996 |
Merck & Co., Inc. is 7.4x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($294.13 B vs $39.81 B).
In their latest fiscal years, TEVA PHARMACEUTICAL INDUSTRIES LTD reported $17.26B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: TEVA PHARMACEUTICAL INDUSTRIES LTD and Merck & Co., Inc., or browse the full rankings.